Up a level |
2016
Harrison, Claire N., Egyed, Miklos, Szoke, Anita, Suvorov, Aleksandr, Perkins, Andrew ORCID: 0000-0003-3644-7093, Mayer, Jiri, Ganly, Peter, Schouten, Harry C., Tosi, Patrizia, Farber, Charles Michael, Zachee, Pierre, Scheid, Christof, Dean, James P., Zhou, Huafeng, Kiladjian, Jean -Jacques, Vannucchi, Alessandro M., Nangalia, Jyoti, Mead, Adam and Mesa, Ruben A. (2016). Pacritinib (PAC) vs best available therapy (BAT) in myelofibrosis (MF): Outcomes in patients (pts) with baseline (BL) thrombocytopenia. J. Clin. Oncol., 34 (15). ALEXANDRIA: AMER SOC CLINICAL ONCOLOGY. ISSN 1527-7755
Harrison, Claire N., Egyed, Miklos, Szoke, Anita, Suvorov, Aleksandr, Perkins, Andrew ORCID: 0000-0003-3644-7093, Mayer, Jiri, Ganly, Peter, Schouten, Harry C., Tosi, Patrizia, Farber, Charles Michael, Zachee, Pierre, Scheid, Christof, Dean, James P., Zhou, Huafeng, Kiladjian, Jean-Jacques, Vannucchi, Alessandro M., Nangalia, Jyoti, Mead, Adam and Mesa, Ruben A. (2016). Outcomes in patients with myelofibrosis and RBC-transfusion dependence in the phase III PERSIST-1 study of pacritinib vs. best available therapy. J. Clin. Oncol., 34 (15). ALEXANDRIA: AMER SOC CLINICAL ONCOLOGY. ISSN 1527-7755